DXN MycoVeggie EU Powder
DXN MycoVeggie EU Powder : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CITRI RETICULATAE | CITRI RETICULATAE[0.03g;5g] | Not identified |
| Syzygium aromaticum | Syzygium aromaticum[0.03g;5g] | Not identified |
| Cinnamomum zeylanicum | Cinnamomum zeylanicum[0.03g;5g] | Not identified |
| Illicium verum | Illicium verum[0.03g;5g] | Not identified |
| SPIRULINA PLATENSIS | SPIRULINA PLATENSIS[0.17g;5g] | Not identified |
| Citrus sinensis | Citrus sinensis[0.17g;5g] | Not identified |
| Citrus aurantiifolia | Citrus aurantiifolia[0.17g;5g] | Not identified |
| Camellia sinensis | Camellia sinensis[0.17g;5g] | Not identified |
| Zea mays | Zea mays[0.17g;5g] | Not identified |
| Lentinus edodes | Lentinus edodes[0.23g;5g] | Not identified |
| LYOPHYLLUM DECASTES | LYOPHYLLUM DECASTES[0.23g;5g] | Not identified |
| Hericium erinaceus | Hericium erinaceus[0.23g;5g] | Not identified |
| Cymbopogon citratus | Cymbopogon citratus[0.23g;5g] | Not identified |
| PLEUROTUS PULMONARIUS | PLEUROTUS PULMONARIUS[0.23g;5g] | Not identified |
| Zingiber officinale | Zingiber officinale[0.23g;5g] | Not identified |
| Calocybe gambosa | Calocybe gambosa[0.23g;5g] | Not identified |
| Morus alba | Morus alba[0.41g;5g] | Not identified |
| Apium graveolens | Apium graveolens[0.41g;5g] | Not identified |
| Ginkgo biloba | Ginkgo biloba[0.41g;5g] | Not identified |
| Plantago ovata | Plantago ovata[1.19g;5g] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL20172835TE
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- DXN PHARMACEUTICAL SDN. BHD.
- Manufacturer
- DXN PHARMACEUTICAL SDN. BHD.
- Registration period starting
- 2022-05-05
- Published validity end
- 2027-05-05
Original register data
View published fields and their variants
- Active ingredients
- CITRI RETICULATAE[0.03g;5g],Syzygium aromaticum[0.03g;5g],Cinnamomum zeylanicum[0.03g;5g],Illicium verum[0.03g;5g],SPIRULINA PLATENSIS[0.17g;5g],Citrus sinensis[0.17g;5g],Citrus aurantiifolia[0.17g;5g],Camellia sinensis[0.17g;5g],Zea mays[0.17g;5g],Lentinus edodes[0.23g;5g],LYOPHYLLUM DECASTES[0.23g;5g],Hericium erinaceus[0.23g;5g],Cymbopogon citratus[0.23g;5g],PLEUROTUS PULMONARIUS[0.23g;5g],Zingiber officinale[0.23g;5g],Calocybe gambosa[0.23g;5g],Morus alba[0.41g;5g],Apium graveolens[0.41g;5g],Ginkgo biloba[0.41g;5g],Plantago ovata[1.19g;5g]
- Valid until
- 2027-05-05
- Registration date
- 2022-05-05
- Published description
- NATURAL PRODUCT
- Licence holder
- DXN PHARMACEUTICAL SDN. BHD.
- Producer
- DXN PHARMACEUTICAL SDN. BHD.
- Published name
- DXN MycoVeggie EU Powder
- Published reference
- 20170207378T
- Registration number
- MAL20172835TE
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20172835TE
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- SPIRULINA PLATENSIS
Read the warning, when it applies and the studies cited
Spirulina
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Allergic rhinitis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Ginkgo biloba
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “DXN MycoVeggie EU Powder”, https://compoatlas.com/en/supplements/malaysia/MAL20172835TE-dxn-mycoveggie-eu-powder, updated 27 October 2026.